The systematic erythalamus (SLE) is a complex self-immunological disease that requires a combination of multiple factors to be judged.
The first is symptoms. Skin symptoms are common, with about 80 per cent of patients suffering different types of skin damage. This is typically a butterfly-shaped red spot, which crosses the nostrils and double cheeks, like a butterfly standing on the face, which is one of the distinctive skin marks of a systematic erythala. There are also plate-shaped red spots, usually in a clear-bordered circular or elliptical shape, which are found in exposed areas such as the head, neck and upper limbs, and which have sticky crumbs, which, after removal of the crumbs, show an increase in the underside of the horny embolden and the furbag. In addition to skin symptoms, patients may be bald and their hair may become thinner and broken.
The overall symptoms cannot be ignored. Many patients have fever symptoms, which are generally low and moderate, but may also be high during acute onset. At the same time, indigence and fatigue are often accompanied by patients and cannot be alleviated even after adequate rest. In addition, joint pain is a common symptom, irritated by multiple joints, such as fingers, wrists, knees, etc., with varying levels of pain, and some patients suffer from morning rigidities, like rheumatism, but the systematic erythroacemia does not usually cause joint malformations like rheumatitis.
Renal stress is also more common in systemic red weeds. Patients may be exposed to protein urine, as shown by the increase in the amount of foam in the urine and its persistence for long periods of time. Serious kidney disorders also lead to edema, which gradually spread to the whole body, starting with the eyelids and lower limbs, as the kidney function is impaired and sodium is left in the body.
The blood system is also affected. Patients may suffer from anaemia, such as paleness, dizziness and panic. Declining white cells can lead to reduced resistance and vulnerability to various pathogens. Declining slabs can cause skin bruises, bruises, nasal cavities and haemorrhage.
In terms of laboratory tests, anti-nuclear antibodies (ANA) testing is an important screening test. Almost all systematic erythalamus patients ANA are positive, but ANA positive is not necessarily systematic erythalamus but may also be found in other groups of people who are immune or healthy. The anti-two-chain DNA antibodies and the anti-Sm antibodies have a high degree of diagnostic specificity to the systemic erythalamus, especially the anti-Sm antibodies, which are the signature antibodies of the systematic erythrophants. If the two are positive, it is important for the diagnosis of a systematic erythalamus.
The testing of patches C3 and C4 is also critical. During the period of systematic erythropopaedic activity, the level of remediality is usually reduced and, as the disease can gradually return to normal, it can help the doctor to determine the level of activity.
In addition to laboratory examinations, there is a need to combine the organization of pathological examinations. For skin-damaged patients, a biopsy can be taken from the dermal pathologies and, under the microscope, pathological changes such as immunoglobins and reductive sediments of the skin can be seen, which can facilitate a clear diagnosis. Renal work tests are also important in determining the type and extent of kidney disease and can provide a basis for the development of treatment programmes.
Systematic erythalamus confirmation is a complex process that requires careful judgement of the multi-faceted findings of clinical doctors combining symptoms, signs, laboratory examinations and the organization of pathology examinations. Since the clinical performance of the disease is diverse and individually diverse, accurate diagnosis is essential for effective follow-up treatment.
